About Us

Archives






Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of…

Posted: June 22, 2021 at 1:50 am


Demonstrates better anti-metastatic activity compared with docetaxel alone

Read this article:
Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of...

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.